# Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study

> **NCT06484725** · — · COMPLETED · sponsor: **IRCCS San Raffaele** · enrollment: 250 (actual)

## Conditions studied

- Breast Cancer
- Genetic Predisposition

## Interventions

- **GENETIC:** Oncotype DX assay

## Key facts

- **NCT ID:** NCT06484725
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06484725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06484725, "Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06484725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*